Healthcare and Medical

home | healthcare and medical | company profile

£265.00
Report Delivery: Via Email
Alerts
Change Currency EuroUSDGBP

ADVENTRX Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis (Datamonitor)

  • Market: Healthcare and Medical
  • Published Date: 06/11/2008
  • Report Title: ADVENTRX Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis
  • Table of Contents: View Table of Contents
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 39
Introduction

ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on anticancer and antiviral treatments that improve the performance and safety of existing drugs by addressing significant problems such as drug metabolism, toxicity, bioavailability or resistance. It has developed a strong proprietary pipeline as a result of its acquisition of SD Pharmaceuticals in April 2006

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    In November 2007, ADVENTRX decided to discontinue its Phase III clinical trial of CoFactor, its lead candidate, for the first-line treatment of metastatic colorectal cancer following advice received from the Data Safety Monitoring Board (DSMB).

    Being a development stage company, ADVENTRX did not record any revenues over 2002-2006.

    The company's key objective is to advance clinical development of its lead candidate, CoFactor (ANX-510). To achieve this, Dendreon plans to enter into collaborations related to CoFactor.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • £265.00   Share Report
     
    Alerts  

    Purchase Information

    There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.

    Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.

    Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

    Worldpay Logo
    Chancy Currency EUR USD GBP
    Customer Area
    English Italian Spanish French German Russian Chinese Arabic